HIV-1 latency in actively dividing human T cell lines
-
* Corresponding author: Ben Berkhout b.berkhout@amc.uva.nl
Retrovirology 2008, 5:37 doi:10.1186/1742-4690-5-37
Accesses
- Last 30 days: 53 accesses
- Last year: 683 accesses
- All time: 4901 accesses
Cited by
BioMed Central: 7 citations
|
Research
Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter Renée M van der Sluis, Georgios Pollakis, Marja L van Gerven, Ben Berkhout, Rienk E Jeeninga Retrovirology 2011, 8:73 (16 September 2011) There were no gross differences among the HIV-1 subtypes, both in the initial latency level and the activation response, except for subtype AE that combines an increased level of basal transcription with a reduced TNFalpha response. This subtype AE property is related to the presence of a GABP instead of NFkappaB binding site in the LTR.
|
|
Review
Laurence Colin, Carine Van Lint Retrovirology 2009, 6:111 (4 December 2009) |
|
Review
The utilization of humanized mouse models for the study of human retroviral infections Rachel Van Duyne, Caitlin Pedati, Irene Guendel, Lawrence Carpio, Kylene Kehn-Hall, Mohammed Saifuddin, Fatah Kashanchi Retrovirology 2009, 6:76 (12 August 2009) |
|
Short report
Andrea Savarino, Antonello Mai, Sandro Norelli, Sary El Daker, Sergio Valente, Dante Rotili, Lucia Altucci, Anna Palamara, Enrico Garaci Retrovirology 2009, 6:52 (2 June 2009) |
|
Review
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs Christopher M Coleman, Li Wu Retrovirology 2009, 6:51 (1 June 2009) |
|
Editorial
The 2008 Retrovirology Prize: Ben Berkhout and his RNA world Kuan-Teh Jeang Retrovirology 2008, 5:113 (11 December 2008) Professor Ben Berkhout of the Netherlands wins the 2008 Retrovirology Prize, awarded annually to an outstanding mid-career retrovirologist.
|
|
Commentary
The aftermath of the Merck's HIV vaccine trial Enrico Iaccino, Marco Schiavone, Giuseppe Fiume, Ileana Quinto, Giuseppe Scala Retrovirology 2008, 5:56 (2 July 2008) |